Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anatole Besarab

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Drugs|December 12, 2001
Darbepoetin Alfa: A Viewpoint by Anatole BesarabAnatole Besarab
Seminars in Dialysis|September 13, 2011
Anemia and iron managementAnatole Besarab
Contributions to Nephrology|January 15, 2004
Vascular access: issues and managementAnatole Besarab
Clinical Journal of the American Society of Nephrology : CJASN|September 19, 2007
More than a decade of experience and still no consensus: controversies in iron therapyAnatole Besarab
Blood Purification|December 20, 2005
Access monitoring is worthwhile and valuableAnatole Besarab
Seminars in Dialysis|January 14, 2004
What common practices in dialysis units can be altered to improve patient care?Anatole Besarab
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2005
Optimizing anaemia management with subcutaneous administration of epoetinAnatole Besarab
Blood Purification|January 23, 2002
Preventing vascular access dysfunction: which policy to followAnatole Besarab
Seminars in Dialysis|March 5, 2002
How can the cardiac death rate be reduced in dialysis patients?Anatole Besarab
Journal of the American Society of Nephrology : JASN|May 30, 2008
Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. ProAnatole Besarab
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Drugs|December 12, 2001
Darbepoetin Alfa: A Viewpoint by Anatole BesarabAnatole Besarab
Seminars in Dialysis|September 13, 2011
Anemia and iron managementAnatole Besarab
Contributions to Nephrology|January 15, 2004
Vascular access: issues and managementAnatole Besarab
Clinical Journal of the American Society of Nephrology : CJASN|September 19, 2007
More than a decade of experience and still no consensus: controversies in iron therapyAnatole Besarab
Blood Purification|December 20, 2005
Access monitoring is worthwhile and valuableAnatole Besarab
Seminars in Dialysis|January 14, 2004
What common practices in dialysis units can be altered to improve patient care?Anatole Besarab
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2005
Optimizing anaemia management with subcutaneous administration of epoetinAnatole Besarab
Blood Purification|January 23, 2002
Preventing vascular access dysfunction: which policy to followAnatole Besarab
Seminars in Dialysis|March 5, 2002
How can the cardiac death rate be reduced in dialysis patients?Anatole Besarab
Journal of the American Society of Nephrology : JASN|May 30, 2008
Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. ProAnatole Besarab
Pageof 9